Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: Jet2 chair buys; Ovoca Bio's old CEO sells to new

15th Jul 2024 13:15

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

----------

Ovoca Bio PLC - Dublin-based biopharmaceutical company with a focus on women's health - Kirill Golovanov resigns as chief executive officer and sells entire shareholding to his replacement and current non-executive director, Timothy McCutcheon. Golovanov will hand over the CEO role to McCutcheon on August 1, having served as an executive director for 12 years. Golovanov cites the end of Ovoca's efforts to develop Orenetide, a treatment for women with hypoactive sexual desire disorder, as the trigger for his departure. Golovanov sells 19.5 million shares to McCutcheon at 0.85p, worth GBP165,803, in a single transaction on Friday outside a trading venue. The shares represent a 23.9% stake.

----------

Jet2 PLC - Leeds, England-based budget airline and package holiday operator - Chair Robin Terrell buys 8,557 shares at GBP13.88, worth GBP118,771, on Friday last week. Now has 13,761 shares.

----------

Warpaint London PLC - Buckinghamshire-based colour cosmetics supplier that owns W7 and Technic brands - Joe Sadler, associate of Non-Executive Director Keith Sadler, sells 16,950 shares at 595 pence and 611p, worth GBP101,653, on Thursday and Friday.

----------

Finseta PLC - London-based foreign exchange and payments solutions - Chief Information Officer Bill Newton sells 338,000 shares in total at average 38.68p, worth GBP130,738, on Thursday and Friday. Retains 2.2 million shares, a 3.8% stake.

----------

Condor Gold PLC - developing La India gold project in Nicaragua - Condor raises GBP220,000 from issuing 1.0 million new shares at 22 pence each for option exercises by Chair Jim Mellon, CEO Mark Child and other employees and consultants. Just over half of the shares will be retained by them, while the other half were sold immediately at 22p. Mellon receives 300,000 shares and now has 53.4 million, a 26% stake. Child receives 100,500 shares and now has 4.8 million.

----------

By Tom Waite, Alliance News editor

Comments and questions to [email protected]

Copyright 2024 Alliance News Ltd. All Rights Reserved.

FTSE 100 Latest
Value8,063.61
Change-7.58